296 related articles for article (PubMed ID: 31911674)
1. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG).
Monaghan KG; Leach NT; Pekarek D; Prasad P; Rose NC;
Genet Med; 2020 Apr; 22(4):675-680. PubMed ID: 31911674
[No Abstract] [Full Text] [Related]
2. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
3. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1381-1390. PubMed ID: 34012068
[No Abstract] [Full Text] [Related]
4. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
[No Abstract] [Full Text] [Related]
5. Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al.
McGurk KA; Zheng SL; Henry A; Josephs K; Edwards M; de Marvao A; Whiffin N; Roberts A; Lumbers TR; O'Regan DP; Ware JS
Genet Med; 2022 Mar; 24(3):744-746. PubMed ID: 34906520
[No Abstract] [Full Text] [Related]
6. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
7. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).
Manickam K; McClain MR; Demmer LA; Biswas S; Kearney HM; Malinowski J; Massingham LJ; Miller D; Yu TW; Hisama FM;
Genet Med; 2021 Nov; 23(11):2029-2037. PubMed ID: 34211152
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
9. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK;
Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919
[No Abstract] [Full Text] [Related]
10. Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Raca G; Astbury C; Behlmann A; De Castro MJ; Hickey SE; Karaca E; Lowther C; Riggs ER; Seifert BA; Thorland EC; Deignan JL;
Genet Med; 2023 Feb; 25(2):100316. PubMed ID: 36507974
[No Abstract] [Full Text] [Related]
11. Correspondence on "Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)" by Dungan et al.
Prensky L; Persson F
Genet Med; 2023 Sep; 25(9):100872. PubMed ID: 37266581
[No Abstract] [Full Text] [Related]
12. Clinical application of medical exome sequencing for prenatal diagnosis of fetal structural anomalies.
Chen M; Chen J; Wang C; Chen F; Xie Y; Li Y; Li N; Wang J; Zhang VW; Chen D
Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():119-124. PubMed ID: 32502767
[TBL] [Abstract][Full Text] [Related]
13. Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
Bush LW; Bartoshesky LE; David KL; Wilfond B; Williams JL; Holm IA;
Genet Med; 2018 Jul; 20(7):692-694. PubMed ID: 29565417
[No Abstract] [Full Text] [Related]
14. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG).
Del Gaudio D; Shinawi M; Astbury C; Tayeh MK; Deak KL; Raca G;
Genet Med; 2020 Jul; 22(7):1133-1141. PubMed ID: 32296163
[No Abstract] [Full Text] [Related]
15. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.
Gregg AR; Skotko BG; Benkendorf JL; Monaghan KG; Bajaj K; Best RG; Klugman S; Watson MS
Genet Med; 2016 Oct; 18(10):1056-65. PubMed ID: 27467454
[TBL] [Abstract][Full Text] [Related]
16. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S;
Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921
[No Abstract] [Full Text] [Related]
17. Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2021 Nov; 23(11):2027-2028. PubMed ID: 34183790
[No Abstract] [Full Text] [Related]
18. Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Matalon DR; Zepeda-Mendoza CJ; Aarabi M; Brown K; Fullerton SM; Kaur S; Quintero-Rivera F; Vatta M;
Genet Med; 2023 Jun; 25(6):100812. PubMed ID: 37058144
[No Abstract] [Full Text] [Related]
19. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Rehder C; Bean LJH; Bick D; Chao E; Chung W; Das S; O'Daniel J; Rehm H; Shashi V; Vincent LM;
Genet Med; 2021 Aug; 23(8):1399-1415. PubMed ID: 33927380
[TBL] [Abstract][Full Text] [Related]
20. Genetics professionals' attitudes toward prenatal exome sequencing.
Brew CE; Castro BA; Pan V; Hart A; Blumberg B; Wicklund C
J Genet Couns; 2019 Apr; 28(2):229-239. PubMed ID: 30888706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
